Description

Product Description:

• Product Name: Oseltamivir Phosphate (equivalent to Oseltamivir)
• Drug Classification: Antiviral Agent
• Strength: 75 mg
• Product Form: Tablets
• Packing Specifications: 10’s

Pharmacokinetics:

Oseltamivir is rapidly absorbed from the gastrointestinal tract after oral administration and is extensively converted to its active metabolite, oseltamivir carboxylate, by hepatic esterases. The bioavailability of oseltamivir is approximately 80%. Oseltamivir carboxylate exhibits dose-proportional pharmacokinetics, with peak plasma concentrations achieved within 3-4 hours after administration. The elimination half-life of oseltamivir carboxylate is approximately 6-10 hours, allowing for convenient twice-daily dosing.

Pharmacodynamics:

Oseltamivir exerts its antiviral activity by inhibiting the neuraminidase enzyme of influenza viruses, thereby preventing the release of newly formed virus particles from infected cells and reducing viral replication. This mechanism of action helps to alleviate symptoms of influenza and shorten the duration of illness.

Formulations:

Oseltamivir Phosphate is available in tablet form, with each tablet containing 75 mg of oseltamivir phosphate, equivalent to oseltamivir.

Indications:

Oseltamivir Phosphate is indicated for the treatment and prophylaxis of influenza virus infection in adults and pediatric patients aged 2 weeks and older. It is effective against influenza A and B viruses, including strains that are resistant to other antiviral medications.

Usage:

Treatment of Influenza: Oseltamivir Phosphate should be initiated within 48 hours of the onset of influenza symptoms. The recommended dosage for treatment in adults and adolescents aged 13 years and older is 75 mg orally twice daily for 5 days.

Prophylaxis of Influenza: For prophylaxis, Oseltamivir Phosphate should be taken once daily for a duration determined by healthcare providers during influenza outbreaks or in high-risk individuals.

Dosage:

The recommended dosage of Oseltamivir Phosphate for both treatment and prophylaxis varies based on age and weight. It is essential to follow the dosing instructions provided by healthcare professionals or as indicated in the product labeling.

Side Effects:

Common side effects of Oseltamivir Phosphate may include nausea, vomiting, headache, and diarrhea. These side effects are usually mild and transient. In rare cases, allergic reactions or neuropsychiatric events such as hallucinations or delirium may occur. Patients should seek medical attention if they experience severe or persistent side effects while taking Oseltamivir Phosphate.

At AIT Pharmaceuticals Division, we prioritize the safety and efficacy of our products to meet the needs of our valued customers. For further information or assistance, please consult your healthcare provider or visit our website